Liu June, Pascal Laura E, Isharwal Sudhir, Metzger Daniel, Ramos Garcia Raquel, Pilch Jan, Kasper Susan, Williams Karin, Basse Per H, Nelson Joel B, Chambon Pierre, Wang Zhou
Department of Urology, University of Pittsburgh School of Medicine, Pennsylvania 15232, USA.
Mol Endocrinol. 2011 Nov;25(11):1849-57. doi: 10.1210/me.2011-1081. Epub 2011 Sep 22.
Determining the source of regenerated luminal epithelial cells in the adult prostate during androgen deprivation and replacement will provide insights into the origin of prostate cancer cells and their fate during androgen deprivation therapy. Prostate stem cells in the epithelial layer have been suggested to give rise to luminal epithelium. However, the extent of stem cell participation to prostate regrowth is not clear. In this report, using prostate-specific antigen-CreER(T2)-based genetic lineage marking/tracing in mice, preexisting luminal epithelial cells were shown to be a source of regenerated luminal epithelial cells in the adult prostate. Prostatic luminal epithelial cells could survive androgen deprivation and were capable of proliferating upon androgen replacement. Prostate cancer cells, typically exhibiting a luminal epithelial phenotype, may retain this intrinsic capability to survive and regenerate in response to changes in androgen signaling, providing part of the mechanism for the ultimate failure of androgen deprivation therapy in prostate cancer.
确定成年前列腺在雄激素剥夺和替代过程中再生管腔上皮细胞的来源,将有助于深入了解前列腺癌细胞的起源及其在雄激素剥夺治疗期间的命运。上皮层中的前列腺干细胞被认为可产生管腔上皮。然而,干细胞参与前列腺再生的程度尚不清楚。在本报告中,利用基于前列腺特异性抗原-CreER(T2)的基因谱系标记/追踪技术在小鼠中进行研究,结果表明成年前列腺中预先存在的管腔上皮细胞是再生管腔上皮细胞的来源。前列腺管腔上皮细胞能够在雄激素剥夺状态下存活,并在雄激素替代时能够增殖。前列腺癌细胞通常表现出管腔上皮表型,可能保留这种内在能力,以响应雄激素信号变化而存活和再生,这为前列腺癌雄激素剥夺治疗最终失败提供了部分机制。